ATE208816T1 - Neues insulinähnliches wachstumsfaktor bindendes protein igfbp-5 - Google Patents

Neues insulinähnliches wachstumsfaktor bindendes protein igfbp-5

Info

Publication number
ATE208816T1
ATE208816T1 AT91918169T AT91918169T ATE208816T1 AT E208816 T1 ATE208816 T1 AT E208816T1 AT 91918169 T AT91918169 T AT 91918169T AT 91918169 T AT91918169 T AT 91918169T AT E208816 T1 ATE208816 T1 AT E208816T1
Authority
AT
Austria
Prior art keywords
growth factor
binding protein
protein
dna molecules
binding
Prior art date
Application number
AT91918169T
Other languages
English (en)
Inventor
Michael C Kiefer
Frank Masiarz
Jurgen Johann Leopold Zapf
Walter Hans Born
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE208816T1 publication Critical patent/ATE208816T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT91918169T 1990-08-28 1991-08-28 Neues insulinähnliches wachstumsfaktor bindendes protein igfbp-5 ATE208816T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57461390A 1990-08-28 1990-08-28
US57739190A 1990-08-31 1990-08-31
PCT/US1991/006141 WO1992003471A1 (en) 1990-08-28 1991-08-28 New insulin-like growth factor binding protein igfbp-5

Publications (1)

Publication Number Publication Date
ATE208816T1 true ATE208816T1 (de) 2001-11-15

Family

ID=27076437

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91918169T ATE208816T1 (de) 1990-08-28 1991-08-28 Neues insulinähnliches wachstumsfaktor bindendes protein igfbp-5

Country Status (8)

Country Link
EP (1) EP0546110B1 (de)
JP (1) JPH06503949A (de)
AT (1) ATE208816T1 (de)
CA (1) CA2090702A1 (de)
DE (1) DE69132814T2 (de)
IE (1) IE913034A1 (de)
PT (1) PT98805B (de)
WO (1) WO1992003471A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5969124A (en) * 1992-06-26 1999-10-19 Case Western Reserve University Nucleotide sequence of L1CAM
DE69333063T2 (de) 1992-11-04 2004-05-13 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Vekürztes insulinähnlichen wachstumsfaktor-bindendes protein mit mitogener aktivität
AU6093794A (en) * 1993-01-29 1994-08-15 Synergen, Inc. Wound healing composition
US5852173A (en) * 1994-10-19 1998-12-22 Genetics Institute, Inc. TNF receptor death ligand proteins and inhibitors of ligand binding
US5712381A (en) * 1994-10-19 1998-01-27 Genetics Institute, Inc. MADD, a TNF receptor death domain ligand protein
US5849501A (en) * 1994-10-19 1998-12-15 Genetics Institute, Inc. TNF receptor death domain ligand proteins and method to identify inhibitors of ligand binding
US5847099A (en) * 1994-10-19 1998-12-08 Genetics Institute, Inc. TNF receptor death domain ligand proteins
AU710568B2 (en) * 1994-12-09 1999-09-23 Human Genome Sciences, Inc. Human vascular IBP-like growth factor
AU7248896A (en) 1995-10-11 1997-04-30 Chiron Corporation Combination pdgf, kgf, igf and igfbp for wound healing
AU2055400A (en) * 1998-12-18 2000-07-03 Human Genome Sciences, Inc. Prostacyclin-stimulating factor-2
EP1820860A3 (de) * 1999-06-02 2008-03-19 Genentech, Inc. Verfahren und Zusammensetzungen zur Hemmung des neoplastischen Zellenwachstums
ATE393220T1 (de) 1999-07-19 2008-05-15 Univ British Columbia Antisense-therapie für hormonregulierte tumoren
US7491816B2 (en) 1999-07-19 2009-02-17 The University Of British Columbia Antisense therapy for hormone-regulated tumors
US20020142963A1 (en) * 2000-10-24 2002-10-03 Andress Dennis L. Methods for increasing bone formation and enhancing bone accretion
AUPR633101A0 (en) * 2001-07-13 2001-08-02 University Of Sydney, The Method
US6750019B2 (en) 2001-10-09 2004-06-15 Isis Pharmaceuticals, Inc. Antisense modulation of insulin-like growth factor binding protein 5 expression
NZ577565A (en) 2001-10-09 2010-10-29 Isis Pharmaceuticals Inc Antisense modulation of insulin-like growth factor binding protein 5 expressions
WO2003062421A1 (en) 2002-01-17 2003-07-31 The University Of British Columbia Bispecific antisense olignucleotides that inhibit igfbp-2 and igfbp-5 and methods of using same
US7538195B2 (en) 2002-06-14 2009-05-26 Immunogen Inc. Anti-IGF-I receptor antibody
WO2005030260A1 (en) 2003-10-01 2005-04-07 The University Of British Columbia Bispecific oligonucleotide for the treatment of cns malignancies
AU2004278311A1 (en) 2003-10-03 2005-04-14 Genentech, Inc. IGF binding proteins
JP5093783B2 (ja) 2006-04-20 2012-12-12 クリングルファーマ株式会社 Ｈｇｆ前駆体蛋白質改変体及びその活性型蛋白質
EP3868396A1 (de) * 2020-02-20 2021-08-25 Enthera S.R.L. Inhibitoren und verwendungen davon

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK131988A (da) * 1988-03-11 1989-09-12 Erasmus University Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur

Also Published As

Publication number Publication date
DE69132814T2 (de) 2002-06-13
DE69132814D1 (de) 2002-01-03
JPH06503949A (ja) 1994-05-12
WO1992003471A1 (en) 1992-03-05
CA2090702A1 (en) 1992-03-01
PT98805A (pt) 1992-08-31
PT98805B (pt) 1999-01-29
EP0546110A1 (de) 1993-06-16
IE913034A1 (en) 1992-03-11
EP0546110A4 (en) 1994-08-17
EP0546110B1 (de) 2001-11-14

Similar Documents

Publication Publication Date Title
DE69132814D1 (de) Neues insulinähnliches wachstumsfaktor bindendes protein igfbp-5
Gospodarowicz et al. Purification of the fibroblast growth factor activity from bovine brain.
ATE208815T1 (de) Genetisches igfbp-5 rodierendes material
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
KR910700257A (ko) 상피 세포에 특이적인 성장인자를 암호하는 dna
KR880701288A (ko) M-csf의 제법
KR880010130A (ko) 폴리 펩티드, dna 및 그의 용도
BG101408A (bg) Аналози на кератиноцитния растежен фактор
BG60256B1 (bg) Рекомбинантен метод за получаване на лимфотоксин
DE3587422D1 (de) Fuer ein hirudinaehnliches protein kodierende dns-sequenz und verfahren zur herstellung eines solchen proteins.
ATE78871T1 (de) Proteinzusammensetzung mit koagulations-wirkung und verfahren zu ihrer herstellung.
DE69324359D1 (de) Verbessertes verfahren zur herstellung von endotoxinbindungsproteinen
ATE68830T1 (de) Verfahren zur erhoehung der ausbeute von heterologen proteinen, produziert durch zuechtung von rekombinanten bakterien.
DE69131979D1 (de) Genetisches igfbp-4 rodierendes material
DE69939330D1 (de) Wachstumsfaktor-homologe zvegf-3
ATE247164T1 (de) Insulinartigen wachstumsfaktor bindendes protein
KR870001311A (ko) 단백질 및 폴리펩티드의 제조 방법
GB8616219D0 (en) Monoclonal antibodies
PT97355A (pt) Processo para a preparacao de polipeptidos recombinantes contendo uma sequencia de aminoacidos de uma proteina de celulas
ATE286069T1 (de) Verfahren zur herstellung rekombinanter pilc- proteine
RU2005123689A (ru) Флуоресцирующие белки из веслоногих ракообразных и способы их применения
SE9704141D0 (sv) New protein and nucleotide sequence, encoding said protein
ATE346919T1 (de) Nebenhoden-spezifisches rezeptorprotein und dessen verwendung
WO1995008628A3 (en) Nucleic acids encoding merosin, merosin fragments and uses thereof
Dixit et al. The isolation of crosslinked peptides of collagen involving α1-CB6

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties